520 results on '"Eschwege E"'
Search Results
2. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: Results from the DIALOG study
3. Type 2 diabetes mellitus in France in 2012: Results from the ObEpi survey
4. Prevalence of treatment for diabetes during 1997–2007, and trends in cardiovascular risk factors between 2001 and 2007 according to diabetic treatment, in the IPC (Investigations Préventives et Cliniques; Preventive and Clinical Investigations) cohort
5. Diabète de type 2 et stratégies thérapeutiques : quelles pratiques aujourd’hui en France ? Résultats de l’enquête EVOLUTIV
6. Itinéraire thérapeutique du diabétique de type 2 : quel impact des variations pondérales sur le risque cardiovasculaire ?
7. Impact of socio-economic position on health and quality of care in adults with Type 2 diabetes in France: the Entred 2007 study
8. Que retenir du bilan d’ENTRED 2007-2010 ?: ENTRED 2007-2010: Which key-points?
9. Insuline glargine en conditions réelles d’utilisation en France: Étude observationnelle menée sur une large population de patients diabétiques de type 1 et de type 2
10. How patients’ attitudes and opinions influence self-care behaviours in type 2 diabetes. Insights from the French DIABASIS Survey
11. Variations pondérales, risque cardiométabolique et impact des médicaments antidiabétiques chez le diabétique de type 2
12. Enquête Diabasis : perception et vécu du diabète par les patients diabétiques: Diabasis survey: Patients’ life experience and perception of the disease
13. Enquête Diabasis : comment le patient diabétique perçoit son traitement et son suivi ?: Diabasis survey: How the diabetic patient perceives his treatment and follow-up?
14. How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey
15. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: A post-hoc analysis of the BIGPRO1 trial
16. Prevalence of diagnosed type 2 diabetes mellitus in the French general population: The INSTANT study
17. Factors Influencing Birth Weight in Newborns of Diabetic and Non-Diabetic Women a Population Based Study
18. EXPLOITATION PAR ORDINATEUR DES ENQUÊTES ALIMENTAIRES QUANTITATIVES PROGRAMME GÉNÉRAL D'ANALYSE NUTRITIONNELLE
19. French medical practice in type 2 diabetes: The need for better control of cardiovascular risk factors
20. Prevalence of macrovascular complications and cardiovascular risk factors in people treated for diabetes and living in France: The ENTRED study 2001
21. Utilisation de l’approche âge-période-cohorte pour l’étude de l’évolution de la prévalence de l’obésité en France dans les études ObEpi
22. Épidémiologie de l’obésité de l’adulte en France Les études Obépi 1997–2006
23. Epidémiologie de la glycémie postprandiale
24. A review of the metabolic syndrome
25. Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the SYMFONIE study
26. Insulin initiation in type 2 diabetic patients admitted in hospital in France and follow-up at 1 year: The “IDAHO 2” study
27. Infant-feeding patterns are related to blood cholesterol concentration in prepubertal children aged 5-11 y: The Fleurbaix-Laventie Ville Sante study
28. Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study: The D.E.S.I.R. study (Data from an Epidemiological Study on the Insulin Resistance syndrome)
29. Evaluation of a screening program for diabetic retinopathy in a primary care setting Dodia (Dépistage ophtalmologique du diabète) study
30. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey
31. The Results of Major Clinical Trials
32. Lecture critique, évaluation, valorisation, information sur les résultats des grands essais cliniques
33. Compte rendu de congrès
34. Evaluation des médicaments après la commercialisation
35. Postmarketing Evaluation of Drugs
36. Risque médicamenteux : prévention
37. Prevention of Drug-Induced Risks
38. Observance du traitement hormonal substitutif de la ménopause : résultats d’une étude prospective française de deux ans, comparant un traitement transdermique et une association fixe par voie orale
39. High death rate from neoplasms in French diabetic and non-diabetic men
40. Pancreatic Cancer and Diabetes
41. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection
42. Microalbuminuria and markers of the atherosclerotic process: the D.E.S.I.R. study
43. Risk Factors for Early Death in Non-Insulin Dependent Diabetes and Men with Known Glucose Tolerance Status.
44. Epidemiological analysis of patients with Type 2 diabetes in France
45. Explanatory Versus Pragmatic Approach in Controlled Clinical Trials, with Special References to Clinical Trials of Platelet-Active Drugs
46. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee
47. Faut-il rétablir l’usage de l’hyperglycémie provoquée orale dans la panoplie d’évaluation du risque vasculaire en cardiologie?
48. Epidemiological data on postprandial glycaemia
49. Tenth Annual Meeting of the European Association for the Study of Diabetes: Jerusalem, Israel, September 11–13, 1974
50. The risk of diabetic control: A comparison of hospital versus general practice supervision
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.